Lipocine (LPCN) Net Equity Issued and Repurchased (2011 - 2025)

Lipocine's (LPCN) quarterly Net Equity Issued and Repurchased came in at $141334.0 in Q3 2025, up 85.97% on a QoQ basis from $76000.0 in Q2 2025.

Lipocine (LPCN) Net Equity Issued and Repurchased (2011 - 2025) Analysis & Trends

Lipocine (LPCN) has 11 years of Net Equity Issued and Repurchased data on file, last reported at $141334.0 in Q3 2025.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $141334.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $217334.0 (up 100.69% YoY) and the FY2024 annual result came in at $209340.0, down 99.35% from the prior year.
Net Equity Issued and Repurchased grew to $141334.0 in Q3 2025, from $76000.0 in the prior quarter.
In the past five years, Net Equity Issued and Repurchased ranged from a high of $32.1 million in Q3 2023 to a low of -$31.7 million in Q3 2022.
A 4-year average of $7.4 million and a median of $108667.0 in 2025 frame the typical range for Net Equity Issued and Repurchased.
Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased jumped 374.79% — and 2023, when it grew 10.19%.
Tracing LPCN's Net Equity Issued and Repurchased over 4 years: stood at $26.8 million in 2021, then sank by 100.02% to -$5900.0 in 2022, then gained by 10.19% to -$5299.0 in 2023, then soared by 2767.18% to $141334.0 in 2025.
The last three Net Equity Issued and Repurchased figures came in at $141334.0 (Q3 2025), $76000.0 (Q2 2025), and -$5299.0 (Q4 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	49.20 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Lipocine	11.15 Mn	-12.76 Mn	-	-

Download Data